noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Nuvalent Inc.

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for[...]
GAVI Alliance

Forgotten pandemic: The cholera emergency in five charts
Pfizer Inc.

Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long Term Clinically Meaningful[...]

Transgene SA

09/14/2024 | Press release | Distributed by Public on 09/14/2024 03:11

Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans l’étude en cours de Phase I/IIa dans les tumeurs solides résistantes

Sharing and Personal Tools

Please select the service you want to use: